Ashfaq R - Search Results

1

Survivin expression is associated with features of biologically aggressive prostate carcinoma.

Shariat SF, Lotan Y, Saboorian H, Khoddami SM, Roehrborn CG, Slawin KM, Ashfaq R. Shariat SF, et al. Among authors: ashfaq r. Cancer. 2004 Feb 15;100(4):751-7. doi: 10.1002/cncr.20039. Cancer. 2004. PMID: 14770431 Free article.

2

Expression of survivin and apoptotic biomarkers in benign prostatic hyperplasia.

Shariat SF, Ashfaq R, Roehrborn CG, Slawin KM, Lotan Y. Shariat SF, et al. Among authors: ashfaq r. J Urol. 2005 Nov;174(5):2046-50. doi: 10.1097/01.ju.0000176459.79180.d1. J Urol. 2005. PMID: 16217391

3

Correlation of cyclin D1 and E1 expression with bladder cancer presence, invasion, progression, and metastasis.

Shariat SF, Ashfaq R, Sagalowsky AI, Lotan Y. Shariat SF, et al. Among authors: ashfaq r. Hum Pathol. 2006 Dec;37(12):1568-76. doi: 10.1016/j.humpath.2006.05.017. Epub 2006 Aug 10. Hum Pathol. 2006. PMID: 16949911

4

Ki-67 is an independent predictor of bladder cancer outcome in patients treated with radical cystectomy for organ-confined disease.

Margulis V, Shariat SF, Ashfaq R, Sagalowsky AI, Lotan Y. Margulis V, et al. Among authors: ashfaq r. Clin Cancer Res. 2006 Dec 15;12(24):7369-73. doi: 10.1158/1078-0432.CCR-06-1472. Clin Cancer Res. 2006. PMID: 17189409

5

Use of combined apoptosis biomarkers for prediction of bladder cancer recurrence and mortality after radical cystectomy.

Karam JA, Lotan Y, Karakiewicz PI, Ashfaq R, Sagalowsky AI, Roehrborn CG, Shariat SF. Karam JA, et al. Among authors: ashfaq r. Lancet Oncol. 2007 Feb;8(2):128-36. doi: 10.1016/S1470-2045(07)70002-5. Lancet Oncol. 2007. PMID: 17267327

6

Caveolin-1 overexpression is associated with aggressive prostate cancer recurrence.

Karam JA, Lotan Y, Roehrborn CG, Ashfaq R, Karakiewicz PI, Shariat SF. Karam JA, et al. Among authors: ashfaq r. Prostate. 2007 May 1;67(6):614-22. doi: 10.1002/pros.20557. Prostate. 2007. PMID: 17299799

7

Survivin expression is associated with bladder cancer presence, stage, progression, and mortality.

Shariat SF, Ashfaq R, Karakiewicz PI, Saeedi O, Sagalowsky AI, Lotan Y. Shariat SF, et al. Among authors: ashfaq r. Cancer. 2007 Mar 15;109(6):1106-13. doi: 10.1002/cncr.22521. Cancer. 2007. PMID: 17311310 Free article.

8

Decreased DOC-2/DAB2 expression in urothelial carcinoma of the bladder.

Karam JA, Shariat SF, Huang HY, Pong RC, Ashfaq R, Shapiro E, Lotan Y, Sagalowsky AI, Wu XR, Hsieh JT. Karam JA, et al. Among authors: ashfaq r. Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4400-6. doi: 10.1158/1078-0432.CCR-07-0287. Clin Cancer Res. 2007. PMID: 17671122

9

Survivin expression in patients with non-muscle-invasive urothelial cell carcinoma of the bladder.

Karam JA, Lotan Y, Ashfaq R, Sagalowsky AI, Shariat SF. Karam JA, et al. Among authors: ashfaq r. Urology. 2007 Sep;70(3):482-6. doi: 10.1016/j.urology.2007.05.009. Urology. 2007. PMID: 17905101

10

Multiple biomarkers improve prediction of bladder cancer recurrence and mortality in patients undergoing cystectomy.

Shariat SF, Karakiewicz PI, Ashfaq R, Lerner SP, Palapattu GS, Cote RJ, Sagalowsky AI, Lotan Y. Shariat SF, et al. Among authors: ashfaq r. Cancer. 2008 Jan 15;112(2):315-25. doi: 10.1002/cncr.23162. Cancer. 2008. PMID: 18008359 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

195 results

Search Page

Filters